Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer

被引:17
作者
Zhang, Wei [1 ]
Wang, Liying [1 ]
Xin, Zhongqiu [1 ]
机构
[1] Gen Hosp, Daqing Oil Field, Dept Ultrasound, Zhongkang St 9, Daqing 163001, Peoples R China
关键词
cancer antigen; contrast enhanced ultrasound; diagnosis; malignant epithelial cancer; ovarian serous carcinoma; TUMORS; CA-125;
D O I
10.1097/MD.0000000000010358
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ovarian serous carcinoma (OSC) is semimalignant ovarian tumors that localized in the ovary at the initial presentation, and can be surgically resected in an excellent prognosis. In contrast, surgical treatment plus adjuvant chemotherapy for ovarian malignant epithelial cancer (OMEC) is the standard treatment stratagem that is painful with poor prognosis and cost quite expensively. Thus, the accurate preoperative differentiation of OSC from OMEC is important for determining the treatment methods and decreasing the cost for individual patients. This study aims to determine whether contrast enhanced ultrasound (CEUS) together with CA19-9/CA125 can improve the ability to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer. The positive rate of cancer antigen (CA) 199 and CA125 in ovarian malignant epithelial tumors was 68% and 94%, respectively, which was a higher incidence than in the serous carcinoma. The mean serum CA19-9 and CA125 concentration was significantly higher in the patients with ovarian malignant epithelial tumors (CA19-9, 514.0 +/- 104.8 U/mL; CA125, 440.0 +/- 154.8 U/mL) than that in the patients with ovarian serous carcinoma (CA19-9, 58.0 +/- 14.3 U/mL; CA125, 63.0 +/- 25.8 U/mL). The time to peak in ovarian serous carcinoma was significantly longer than in ovarian malignant epithelial tumors. However, the peak intensity, area under the curve, and washout time in ovarian serous carcinoma were significantly lower than in ovarian malignant epithelial tumors. The addition of CA19-9/CA125 increased the sensitivities from 79% CEUS only to 85% for CEUS plus CA19-9/CA125 data, and increased the specificities from 65% CEUS only to 91% for CEUS plus the CA19-9/CA125 information. Thus, the addition of the serum CA19-9/CA125 levels to parametric CEUS data was of significant diagnostic value for differentiating OSC from OMEC.
引用
收藏
页数:4
相关论文
共 15 条
  • [11] Sconfienza L M, 2010, J Ultrasound, V13, P9, DOI 10.1016/j.jus.2009.09.007
  • [12] The Serum CA-125 Concentration Data Assists in Evaluating CT Imaging Information When Used to Differentiate Borderline Ovarian Tumor from Malignant Epithelial Ovarian Tumors
    Shin, Ji-Eun
    Choi, Hyuck Jae
    Kim, Mi-hyun
    Cho, Kyoung-Sik
    [J]. KOREAN JOURNAL OF RADIOLOGY, 2011, 12 (04) : 456 - 462
  • [13] Smolle E, 2014, ANTICANCER RES, V34, P1553
  • [14] Prognosis in Patients With Serous and Mucinous Stage I Borderline Ovarian Tumors
    Song, Taejong
    Lee, Yoo-Young
    Choi, Chel Hun
    Kim, Tae-Joong
    Lee, Jeong-Won
    Kim, Byoung-Gie
    Bae, Duk-Soo
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (05) : 770 - 777
  • [15] Study on the Characteristics of Contrast-Enhanced Ultrasound and Its Utility in Assessing the Microvessel Density in Ovarian Tumors or Tumor-Like Lesions
    Wang, Junyan
    Lv, Faqin
    Fei, Xiang
    Cui, Qiuli
    Wang, Longxia
    Gao, Xuewen
    Yuan, Zhixian
    Lin, Qian
    Lv, Yali
    Liu, Aijun
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2011, 7 (05): : 600 - 606